ServiceEnschede, NetherlandsFounded 2004· One of 1982 Service companies tracked by AMPulse
Produces complex fine mechanical metal parts via metal injection moulding (MIM) with proprietary biodegradable feedstocks for medical and luxury applications.
CEO / Founder
Dennis Schipper
Team Size
11-50
Stage
Active
Total Funding
Undisclosed
Key Investors
Demcon Group (parent company)
Technology & Products
Key Products
Complex fine mechanical metal parts via metal injection moulding (MIM) with proprietary biodegradable feedstocks.
Technological Advantage
Integration with the broader Demcon Group's mechatronic engineering ecosystem allows for advanced 'Design for MIM' optimization that standard contract manufacturers cannot match.
Differentiation
Value Proposition
Reduces production costs for complex metal parts by up to 50% compared to CNC machining while achieving 99%+ density and high-gloss surface finishes for medical and luxury goods.
How They Differentiate
3x higher precision through mechatronic-led design and unique eco-friendly feedstock that supports a wider range of exotic alloys than standard MIM providers.
Market & Competition
Target Customers
Medical device OEMs, luxury watch and goods manufacturers, and industrial technology companies requiring high-precision small metal components.
Demcon Group: >€100M annual turnover; 1,000+ employees across international locations; MIM division is a profit center within larger engineering group
Major Milestones
Development of proprietary biodegradable feedstock; Successful redesign of Fixus orthopedic fixation devices; Production of Secrid Premium collection high-gloss metal components
DEMCON metal injection moulding B.V. occupies a niche within the broader Demcon Group, applying metal injection moulding (MIM) to produce small, complex metal components. Its primary differentiator is a proprietary biodegradable feedstock that supports stainless steel and exotic alloys, enabling high-gloss surface finishes without the environmental footprint of conventional binder systems. The company targets applications where precision and aesthetics matter more than raw part size.
The core technology is MIM, a process that combines powder metallurgy with injection moulding to create near-net-shape metal parts. DEMCON's version achieves 99%+ density and dimensional tolerances that it claims are three times tighter than standard MIM providers, a result of integrating mechatronic engineering expertise from the parent group's 'Design for MIM' optimization. This allows the company to serve medical device OEMs requiring orthopedic fixation devices and luxury goods manufacturers producing high-gloss metal components for items like the Secrid Premium collection.
Customer segments include medical OEMs, luxury watch and goods makers, and industrial technology firms needing high-precision small metal parts. Named customers include Fixus, for which DEMCON redesigned orthopedic fixation devices, and Secrid, a wallet manufacturer. The company operates from Enschede, Netherlands, as a profit center within the Demcon Group, which reports over €100 million in annual turnover and more than 1,000 employees across international locations.
DEMCON's strategic moat lies in its proprietary biodegradable feedstock and the engineering support from the Demcon Group's mechatronics ecosystem, which standard MIM contract manufacturers cannot easily replicate. Competitive risk comes from larger MIM players such as Indo-MIM and ARC Group Worldwide, which have broader production scale and established supply chains. The company's focus on small-to-medium batch runs for medical and luxury verticals may limit its addressable market but also insulates it from high-volume commodity MIM pricing pressure.
Competitive Intelligence
Competitors, SWOT analysis, and investment insights